Ifosfamide

异环磷酰胺

Report date: 2022/03/23 14:30:13
NME

Base Information

Drug NameIfosfamide
Drug Alias NameIfomide异环磷醯胺异磷酰胺IfosfamidumIfosfamida +[13] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAlkylating agentsDNA inhibitors
TargetsDNA
Therapy Area/IndicationsLung NeoplasmsTesticular NeoplasmsOvarian Neoplasms +[12] 
Global Approved IndicationsLung NeoplasmsTesticular NeoplasmsOvarian Neoplasms +[6] 
Approved Indications in ChinaLung NeoplasmsTesticular NeoplasmsOvarian Neoplasms +[6] 
Original Approved Country/TerritoryFrance
Original Approved Date1976/01/01
Country/TerritoryUnited StatesPuerto RicoAustralia +[7] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesBaxter International Inc
China Registration ClassN/A

Develop Information

Active CompaniesBaxter HlthcareBaxter International IncJiangsu Hengrui Medicine Co Ltd
Inactive CompaniesNational Cancer InstituteGrupo Espanol De Investigacion En Sarco
Active IndicationsLung NeoplasmsTesticular NeoplasmsOvarian Neoplasms +[6] 
Inactive IndicationsHemangiopericytomaMeningiomaRhabdomyosarcoma +[6] 

Other Information

ATC CodeL01AA06
Related LinksWikipediaDrugBankKEGG